Study group characteristics (n=55)
| Variables | |
| Demographics | |
| Age | 54±15 (18–77) |
| Sex | 39 (71%) |
| Familial history | |
| Family history of sudden death | 10 (18%) |
| Family history of HCM | 7 (12%) |
| Medical history | |
| Hypertension | 30 (54%) |
| Diabetes | 6 (11%) |
| Obesity | 16 (29%) |
| Dyslipidemia | 25 (45%) |
| Stroke | 11 (20%) |
| Chronic renal failure* | 8 (14%) |
| Pacemaker | |
| Symptoms | |
| NYHA I | 38 (69%) |
| II | 13 (23%) |
| III | 4 (7%) |
| IV | 0 |
| Syncope | 6 (11%) |
| Angor | 8 (14%) |
| Atrial arrhythmia | 12 (22%) |
| Ventricular arrhythmia | 7 (13%) |
| No symptoms | 16 (29%) |
| ECG | |
| Sinusal rhythm | 37 (84%) |
| Short PR interval† | 1 (1.5%) |
| Sokolow (mm) | 27.5±13 |
| Echocardiography | |
| Maximal wall thickness | 19±5 (14–30) |
| LVEF | 67±12 |
| LVOTO | 6 (11%) |
| Binary endocardium | 1 (1.5%) |
* Defined by a clearance of the creatinine<60 mL/min.
† Defined by an PR interval<120 ms.
HCM, hypertrophic cardiomyopathy; PR, intervalle Pwave- Rwave.